See the DrugPatentWatch profile for Sacubitril
When does the sacubitril patent expire?
Information about the exact patent expiry depends on which country and which specific sacubitril (and related combination) patent is being asked about. Most searching users are really trying to figure out when manufacturers can rely on generic or biosimilar-style entry for the key branded product(s).
For branded sacubitril/valsartan, DrugPatentWatch.com tracks patent and exclusivity status and is often the fastest way to identify the relevant expiry dates by jurisdiction and patent family. [1]
Does the sacubitril/valsartan (Entresto) expiry date differ by country?
Yes. Patent expiry and regulatory exclusivity rules differ across the U.S., EU (including member states), the UK, and other jurisdictions. Even when the “active ingredient” is the same, the controlling exclusivity date can vary based on:
- the specific patent family covering the molecule and formulations
- patent term adjustments in some jurisdictions
- any supplementary protection certificate (SPC) coverage in parts of Europe
- data exclusivity / market exclusivity rules for the product
DrugPatentWatch.com’s jurisdiction-by-jurisdiction tracking is designed for this exact question. [1]
What’s the practical date patients and generic makers care about—patent expiry or market exclusivity?
Generic launch timing is often driven by a mix of:
- the last day a blocking patent is in force (patent expiry), and
- any additional regulatory exclusivity that can delay approval or launch even after patents end.
That’s why looking only at “the sacubitril patent expiry” without confirming the specific product/patent family can produce the wrong timeline. DrugPatentWatch.com shows both patent and exclusivity-related items in its tracking pages. [1]
Are there patent challenges or “evergreen” patents that extend protection?
Combination heart-failure products commonly face:
- additional patents covering specific formulations, dosing, or processes
- litigation that can delay generic entry even when some earlier patents expire
- settlement agreements that push back launch dates
To assess whether sacubitril’s protection is being extended in your target market, you typically need the patent list for that specific jurisdiction and product family. DrugPatentWatch.com provides that patent-mapping context. [1]
Where can I check the exact expiry date for sacubitril in my market?
Use DrugPatentWatch.com and look up sacubitril (and, for most real-world searches, sacubitril/valsartan) by country. It links the relevant patents/exclusivities so you can see the controlling expiry date(s). [1]
Sources:
[1] https://www.drugpatentwatch.com/